Evidence map›Paper›PMID 39446034›Full record

ReviewImmunoHorizons2024

Comparison of B Cell Variable Region Gene Segment Characteristics in Neuro-autoantibodies.

Hend Abd El Baky, Nadav I Weinstock, Gull Zareen Khan Sial, Mark D Hicar

Abstract readComparative StudyReview
In one paragraph

Review in ImmunoHorizons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hend Abd El BakyDepartment of Pediatrics, University at Buffalo, Buffalo, NY.
Nadav I WeinstockMcKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Gull Zareen Khan SialDepartment of Child Neurology, University of Pittsburgh Medical Center, Harrisburg Hospital, Harrisburg, PA.
Mark D HicarDepartment of Pediatrics, University at Buffalo, Buffalo, NY.ORCID 0000-0002-1768-5419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune pediatric neurologic diseases have variable phenotypes and presentations, making diagnosis challenging. The pathologic mechanisms are also distinct, including cell-mediated and Ab-mediated autoimmunity, paraneoplastic syndromes, and postinfectious processes. In recent years a number of studies have described the characteristics of the autoantibodies involved in a number of these diseases. Some of the described Abs use a restricted set of variable gene segments. We sought to compare the Ab characteristics of autoantibodies related to some of the more common disorders to discover whether specific Ab signatures are universally associated with neuroautoimmune diseases. We initially performed a literature review to summarize the Ab characteristics of autoantibodies related to some of the more common disorders, including N-methyl-d-aspartate receptor (NMDAR) and leucine-rich, glioma-inactivated 1 (LGI-1). Next, we performed data analysis from selected studies that sequenced Ig genes to further characterize NMDAR and LGI-1 autoantibodies including CDR3 length distribution, variable gene sequence usage, and isotype use. We found that CDR3 length of NMDAR autoantibodies was normally distributed whereas the CDR3 length distribution of LGI-1 autoantibodies was skewed, suggesting that there is no global structural restriction on types of autoantibodies that can cause encephalitis. We also found that IgG1-IgG3 were the main NMDAR autoantibody isotypes detected, while IgG4 was the major isotype used in autoantibodies from LGI-1 encephalitis. These findings are useful for our understanding of autoimmune encephalitis and will help facilitate better diagnosis and treatment of these conditions in the future.

Indexed as

AutoantibodiesAutoimmune Diseases of the Nervous SystemReceptors, N-Methyl-D-AspartateB-LymphocytesComplementarity Determining RegionsEncephalitisHashimoto DiseaseHumansImmunoglobulinsIntracellular Signaling Peptides and ProteinsProteinsAutoantibodiesComplementarity Determining RegionsImmunoglobulinsIntracellular Signaling Peptides and ProteinsLGI1 protein, humanProteinsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID39446034
PMCPMC11532373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.